Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Ifrd2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IFRD2 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | increases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of IFRD2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Ifrd2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of IFRD2 mRNA] | CTD | PMID:22206623 | 14-Deoxy-11,12-didehydroandrographolide | decreases expression | EXP | | 6480464 | 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of IFRD2 mRNA | CTD | PMID:22101062 | 17alpha-ethynylestradiol | increases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of IFRD2 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IFRD2 mRNA | CTD | PMID:20823114 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of IFRD2 mRNA | CTD | PMID:31614463 | 17beta-estradiol | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of IFRD2 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IFRD2 mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IFRD2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of IFRD2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of IFRD2 mRNA | CTD | PMID:21215274 | 2,4-dinitrotoluene | affects expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of IFRD2 mRNA | CTD | PMID:21346803 | 2-butoxyethanol | increases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | n-butoxyethanol results in increased expression of IFRD2 mRNA | CTD | PMID:19812364 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Ifrd2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of IFRD2 exon | CTD | PMID:33297965 | 4-amino-2,6-dinitrotoluene | affects expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of IFRD2 mRNA | CTD | PMID:21346803 | 4-hydroxyphenyl retinamide | increases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of IFRD2 mRNA | CTD | PMID:28973697 | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IFRD2 mRNA more ... | CTD | PMID:32699268 and PMID:32845096 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of IFRD2 mRNA | CTD | PMID:32763439 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of IFRD2 mRNA | CTD | PMID:23724009 and PMID:33167477 | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IFRD2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of IFRD2 mRNA | CTD | PMID:32699268 | antimycin A | increases expression | EXP | | 6480464 | Antimycin A results in increased expression of IFRD2 mRNA | CTD | PMID:33512557 | Aroclor 1254 | decreases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of IFRD2 mRNA | CTD | PMID:23650126 | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of IFRD2 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of IFRD2 mRNA | CTD | PMID:21715664 | bisphenol A | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of IFRD2 mRNA | CTD | PMID:25181051 and PMID:32145629 | bisphenol A | decreases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of IFRD2 mRNA | CTD | PMID:33296240 | bisphenol A | decreases methylation | ISO | Ifrd2 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of IFRD2 promoter | CTD | PMID:27312807 | bortezomib | decreases expression | EXP | | 6480464 | Bortezomib results in decreased expression of IFRD2 mRNA | CTD | PMID:20977926 | bucladesine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IFRD2 mRNA | CTD | PMID:20823114 | cadmium dichloride | decreases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Cadmium Chloride results in decreased expression of IFRD2 mRNA | CTD | PMID:20883709 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of IFRD2 mRNA | CTD | PMID:19320972 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of IFRD2 mRNA | CTD | PMID:19167446 | crocidolite asbestos | increases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of IFRD2 mRNA | CTD | PMID:29279043 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of IFRD2 mRNA | CTD | PMID:20106945 and PMID:27989131 | daidzein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of IFRD2 mRNA | CTD | PMID:16963248 | deguelin | increases expression | EXP | | 6480464 | deguelin results in increased expression of IFRD2 mRNA | CTD | PMID:33512557 | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of IFRD2 gene | CTD | PMID:22964155 | dibutyl phthalate | decreases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of IFRD2 mRNA | CTD | PMID:21266533 | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of IFRD2 mRNA | CTD | PMID:26516004 | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of IFRD2 mRNA | CTD | PMID:18175754 | elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of IFRD2 mRNA | CTD | PMID:19244175 | endosulfan | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of IFRD2 mRNA | CTD | PMID:29391264 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IFRD2 mRNA | CTD | PMID:19167446 | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of IFRD2 mRNA | CTD | PMID:23649840 | fenthion | increases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Fenthion results in increased expression of IFRD2 mRNA | CTD | PMID:34813904 | flutamide | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of IFRD2 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Ifrd2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of IFRD2 mRNA] | CTD | PMID:22206623 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of IFRD2 mRNA | CTD | PMID:23649840 | furan | increases methylation | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | furan results in increased methylation of IFRD2 gene | CTD | PMID:22079235 | gallic acid | increases expression | EXP | | 6480464 | Gallic Acid results in increased expression of IFRD2 mRNA | CTD | PMID:34408198 | genistein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of IFRD2 mRNA | CTD | PMID:16963248 | gentamycin | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of IFRD2 mRNA | CTD | PMID:33387578 | glycidyl methacrylate | increases expression | EXP | | 6480464 | glycidyl methacrylate results in increased expression of IFRD2 protein | CTD | PMID:36641056 | glycitein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of IFRD2 mRNA | CTD | PMID:16963248 | glyphosate | increases methylation | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Glyphosate results in increased methylation of IFRD2 gene | CTD | PMID:31011160 | inulin | multiple interactions | ISO | Ifrd2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of IFRD2 mRNA | CTD | PMID:36331819 | medroxyprogesterone acetate | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of IFRD2 mRNA | CTD | PMID:20823114 | methidathion | increases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | methidathion results in increased expression of IFRD2 mRNA | CTD | PMID:34813904 | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of IFRD2 mRNA | CTD | PMID:23649840 | methylseleninic acid | decreases expression | EXP | | 6480464 | methylselenic acid results in decreased expression of IFRD2 mRNA | CTD | PMID:18548127 | nefazodone | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of IFRD2 mRNA | CTD | PMID:24136188 | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of IFRD2 mRNA | CTD | PMID:24768652 and PMID:25583101 | nimesulide | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | nimesulide results in increased expression of IFRD2 mRNA | CTD | PMID:24136188 | oxaliplatin | decreases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | oxaliplatin results in decreased expression of IFRD2 mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of IFRD2 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of IFRD2 mRNA more ... | CTD | PMID:32699268 and PMID:32845096 | ozone | multiple interactions | ISO | Ifrd2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of IFRD2 mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of IFRD2 mRNA | CTD | PMID:17562736 | paraquat | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of IFRD2 mRNA | CTD | PMID:32680482 | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of IFRD2 mRNA | CTD | PMID:32588087 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ifrd2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IFRD2 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of IFRD2 mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | perfluorooctanoic acid results in increased expression of IFRD2 mRNA | CTD | PMID:35163327 | picoxystrobin | increases expression | EXP | | 6480464 | picoxystrobin results in increased expression of IFRD2 mRNA | CTD | PMID:33512557 | pirinixic acid | multiple interactions | ISO | Ifrd2 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of IFRD2 mRNA | CTD | PMID:19710929 | pyrimidifen | increases expression | EXP | | 6480464 | pyrimidifen results in increased expression of IFRD2 mRNA | CTD | PMID:33512557 | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of IFRD2 mRNA | CTD | PMID:19167446 | rotenone | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of IFRD2 mRNA | CTD | PMID:28374803 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of IFRD2 mRNA | CTD | PMID:33512557 | selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of IFRD2 mRNA | CTD | PMID:19244175 | sodium arsenite | decreases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of IFRD2 mRNA | CTD | PMID:20883709 and PMID:25270620 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of IFRD2 mRNA | CTD | PMID:31533062 | tetrachloromethane | affects expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of IFRD2 mRNA | CTD | PMID:17484886 | tetrachloromethane | increases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of IFRD2 mRNA | CTD | PMID:31919559 | thioacetamide | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of IFRD2 mRNA | CTD | PMID:23411599 | thioacetamide | decreases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of IFRD2 mRNA | CTD | PMID:34492290 | topotecan | multiple interactions | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of IFRD2 mRNA | CTD | PMID:25729387 | trichloroethene | increases expression | ISO | Ifrd2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of IFRD2 mRNA | CTD | PMID:33387578 | triptonide | decreases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | triptonide results in decreased expression of IFRD2 mRNA | CTD | PMID:33045310 | trovafloxacin | decreases expression | ISO | Ifrd2 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of IFRD2 mRNA | CTD | PMID:35537566 | uranium atom | affects expression | EXP | | 6480464 | Uranium affects the expression of IFRD2 mRNA | CTD | PMID:15672453 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of IFRD2 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of IFRD2 mRNA | CTD | PMID:23179753 | |